To directly investigate the contribution of PD-L1 in the antitumor effects of SFN in immunocompetent mice, we conducted tumor assays using CT26 cells with stable overexpression of PD-L1 (Fig. 6D). The gene discussed is CD274; the disease is neoplasm.